retatrutide phase 2 trial 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide Delivers Significant Hemoglobin A1C

That support can be especially important during the summer, when heat, travel, activity, schedule changes, and social events may affect your routine

Sustainable financing strategies become mandatory for patients considering long-term GLP-1 therapy protocols

Depending on the route of administration (and the GLP-1R agonist used), peripherally administered GLP-1 analogs seem either to act directly in the hypothalamus and hindbrain, both areas with incomplete BBB, or else on vagal afferents to transmit the signal to the hindbrain which then projects to other key feeding areas in the brain

Microbial regulation of the L cell transcriptome

The impacts of decreased NAD + levels on various organ dysfunctions have been investigated using genetically engineered Nampt -knockout (NKO) mice models

I want to be honest that these are not approved treatments for lupus or Sjgrens